Instrument NameJohnson & JohnsonInstrument Symbol(JNJ-N)

Instrument ExchangeNYSE

This two-step strategy could set investors up with a large sum of passive income in retirement.

The biotech continues to earn important wins, but is it enough?

Telemedicine was one of the most in-demand services during the height of the COVID-19 pandemic.

You can take these dividends straight to the bank.

Global Markets Canada Canada’s main stock index experienced a modest increase, driven primarily by gains in crude oil and metal prices.  Vancouver and Toronto’s housing markets saw sales decline steadily in August as consumers struggle with their balance sheets amid cost struggles. United States American stock markets were volatile, as...

Johnson & Johnson and Altria Group are two prominent dividend stocks, but I wouldn't rely on their payouts.

While technology stocks continue to struggle, stocks in the lucrative over-the-counter healthcare products sector are thriving. One prominent such name is Haleon. Its stock has jumped more than 22% over the past three months, as sales and profits in its nine large-scale multinational, high-margin 'power brands' continue to hold leading market shares in growing categories.

The judge found after a two-week trial that Johnson & Johnson had breached a merger agreement and failed to support the acquired iPlatform technology

These companies have excellent records of growing their dividends.

You won't find a more dependable dividend payer on Wall Street. But whether it's the best stock for you depends on other factors.

Investing in equal parts of these five stocks produces an average dividend yield of 3%.

Get paid a dividend on a monthly basis.

Dividend King J&J can boost its MedTech business with Nvidia’s help.

There's no reason to succumb to gloom and doom here.

Now could be a great time to buy excellent dividend stocks, but these two ETFs have different approaches.

This relative unknown hasn't missed a dividend payment to its shareholders in more than 200 years!

These stocks have quality businesses behind them.

Some of Trump's Dividend Kings deserve a crown more than others.

The company hasn't performed well in recent years,

Motley Fool analysts talk over market news including earnings updates from Home Depot, Walmart, and Brinker.

This leading pharmaceutical stock is flying under the radar right now.

This dividend aristocrat crushed Q2 earnings and issued strong guidance, and still has some fuel left in the tank for more growth.

Pharmaceutical giant Johnson & Johnson (JNJ) is buying privately held medical device maker V-Wave for ...

The deal is expected to boost Johnson & Johnson’s earnings by about 24 cents in 2024, and by 6 cents in 2025

Dividend growth stocks offer investors a powerful combination of income and capital appreciation potential, making them attractive for long-term portfolios.